| Familial chilblain lupus due to a gain-of-function mutation in STING N König, C Fiehn, C Wolf, M Schuster, EC Costa, V Tüngler, HA Alvarez, ... Annals of the rheumatic diseases 76 (2), 468-472, 2017 | 283 | 2017 |
| Defective removal of ribonucleotides from DNA promotes systemic autoimmunity C Günther, B Kind, MAM Reijns, N Berndt, M Martinez-Bueno, C Wolf, ... The Journal of clinical investigation 125 (1), 413-424, 2015 | 212 | 2015 |
| Single-stranded nucleic acids promote SAMHD1 complex formation V Tüngler, W Staroske, B Kind, M Dobrick, S Kretschmer, F Schmidt, ... Journal of molecular medicine 91, 759-770, 2013 | 89 | 2013 |
| Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord L Garay, V Tüngler, MCG Deniselle, A Lima, P Roig, AF De Nicola Neuroscience 192, 588-597, 2011 | 62 | 2011 |
| Naturally Occurring Genetic Variants of Human Caspase‐1 Differ Considerably in Structure and the Ability to Activate Interleukin‐1β H Luksch, MJ Romanowski, O Chara, V Tüngler, ER Caffarena, ... Human mutation 34 (1), 122-131, 2013 | 39 | 2013 |
| Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children E Nitz, M Smitka, J Schallner, K Akgün, T Ziemssen, M von der Hagen, ... Annals of Clinical and Translational Neurology 8 (10), 2013-2024, 2021 | 37 | 2021 |
| Response to:‘JAK inhibition in STING-associated interferonopathy’by Crow et al V Tüngler, N König, C Günther, K Engel, C Fiehn, M Smitka, ... Annals of the Rheumatic Diseases 75 (12), e76-e76, 2016 | 34 | 2016 |
| Therapeutic approaches to type I interferonopathies M Bienias, N Brück, C Griep, C Wolf, S Kretschmer, B Kind, V Tüngler, ... Current rheumatology reports 20, 1-9, 2018 | 32 | 2018 |
| High association of MOG-IgG antibodies in children with bilateral optic neuritis EM Wendel, M Baumann, N Barisic, A Blaschek, EC de Oliveira Koch, ... European Journal of Paediatric Neurology 27, 86-93, 2020 | 31 | 2020 |
| Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome V Tungler, RM Silver, H Walkenhorst, C Gunther, MA Lee-Kirsch Br J Dermatol 167 (1), 212-4, 2012 | 24 | 2012 |
| Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome EM Wendel, HS Thonke, A Bertolini, M Baumann, A Blaschek, ... Neurology: Neuroimmunology & Neuroinflammation 9 (6), e200035, 2022 | 22 | 2022 |
| Variable clinical phenotype in two siblings with Aicardi-Goutieres syndrome type 6 and a novel mutation in the ADAR gene L Schmelzer, M Smitka, C Wolf, N Lucas, V Tüngler, G Hahn, A Tzschach, ... European Journal of Paediatric Neurology 22 (1), 186-189, 2018 | 21 | 2018 |
| Management of external small bowel fistulae: challenges and controversies confronting the general surgeon DE Wainstein, V Tüngler, C Ravazzola, O Chara International Journal of Surgery 9 (3), 198-203, 2011 | 15 | 2011 |
| Phenotypic Variability in a Family with Aicardi-Goutières Syndrome Due to the Common A177T RNASEH2B Mutation V Tüngler, F Schmidt, S Hieronimus, C Reyes-Velasco, MA Lee-Kirsch Case Reports in Clinical Medicine 2014, 2014 | 11 | 2014 |
| Effect of intestinal pressure on fistula closure during vacuum assisted treatment: A computational approach DI Cattoni, C Ravazzola, V Tüngler, DE Wainstein, O Chara International Journal of Surgery 9 (8), 662-668, 2011 | 6 | 2011 |
| Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis HT Hölzer, F Boschann, JB Hennermann, G Hahn, A Hermann, ... Journal of Neurology 268, 2259-2262, 2021 | 5 | 2021 |
| Aicardi-Goutières syndrome due to a paternal mosaic IFIH1 mutation V Tüngler, M Doebler-Neumann, M Salandin, P Kaufmann, C Wolf, ... Neurology: Genetics 6 (1), e384, 2019 | 5 | 2019 |
| Thymulin-based gene therapy and pituitary function in animal models of aging PC Reggiani, B Poch, GM Cónsole, OJ Rimoldi, JI Schwerdt, V Tüngler, ... Neuroimmunomodulation 18 (5), 350-356, 2011 | 4 | 2011 |
| Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges S Bayoumy, IMW Verberk, L Vermunt, E Willemse, B den Dulk, ... Clinical Chemistry and Laboratory Medicine (CCLM), 2024 | 3 | 2024 |
| Typ-1-Interferonopathien V Tüngler, M Lee-Kirsch Arthritis und Rheuma 34 (04), 225-233, 2014 | 3 | 2014 |
